Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Drug Safety|October 16, 2012
Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the NetherlandsSigrid Piening, Flora M Haaijer-Ruskamp, Pieter A de Graeff, et al.
International Journal of Clinical Pharmacy|April 8, 2016
Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorderMarlies M E Geurts, Roy E Stewart, Jacobus R B J Brouwers, et al.
British Journal of Clinical Pharmacology|April 20, 2011
Additional safety risk to exceptionally approved drugs in Europe?Arna H Arnardottir, Flora M Haaijer-Ruskamp, Sabine M J Straus, et al.
Drug Safety|May 22, 2010
A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009Peter G M Mol, Sabine M J M Straus, Sigrid Piening, et al.
Kidney International|March 23, 2012
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockersHiddo J Lambers Heerspink, Frank A Holtkamp, Hans-Henrik Parving, et al.
Archives of Internal Medicine|February 14, 2007
Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort studyElizabeth F W van Vlijmen, Jan-Leendert P Brouwer, Nic J G M Veeger, et al.
British Journal of Clinical Pharmacology|December 4, 2014
Understanding drug preferences, different perspectivesPeter G M Mol, Arna H Arnardottir, Sabine M J Straus, et al.
Drug Safety|April 7, 2012
Impact of safety-related regulatory action on clinical practice: a systematic reviewSigrid Piening, Flora M Haaijer-Ruskamp, Jonie T N de Vries, et al.
European Heart Journal|March 23, 2011
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trialsFrank A Holtkamp, Dick de Zeeuw, Pieter A de Graeff, et al.
Drug Safety|September 20, 2013
Post-approval safety issues with innovative drugs: a European cohort studyPeter G M Mol, Arna H Arnardottir, Domenico Motola, et al.
Pageof 3